INIS
kidneys
100%
diseases
75%
receptors
65%
patients
58%
urokinase
48%
plasminogen
38%
proteins
36%
levels
32%
mice
25%
injuries
25%
humans
19%
risks
18%
actin
17%
therapy
17%
filtration
15%
microtubules
14%
inflammation
13%
mortality
11%
in vivo
11%
coronaviruses
10%
biological markers
10%
genes
9%
diaphragm
9%
control
9%
comparative evaluations
9%
losses
8%
genetics
8%
death
8%
mutations
8%
data
8%
damage
8%
antibodies
7%
failures
7%
barriers
7%
interactions
7%
plasma
7%
transplants
7%
cancer
7%
glomeruli
7%
covid-19
7%
pathogenesis
6%
in vitro
6%
reviews
6%
adults
6%
glucose
6%
dynamics
6%
induction
6%
organs
6%
dialysis
5%
regulations
5%
Medicine and Dentistry
Urokinase Receptor
30%
Podocyte
27%
Patient
25%
Focal Segmental Glomerulosclerosis
17%
COVID-19
14%
Nephropathy
11%
Kidney
10%
Therapeutic Procedure
10%
Proteinuria
10%
Inpatient
8%
Cells
7%
Biological Marker
6%
Glomerulopathy
5%
Disease
5%
Mortality
5%
Nephrotic Syndrome
5%
Death
5%
Keyphrases
Podocyte
15%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
15%
Focal Segmental Glomerulosclerosis
9%
COVID-19
6%